# Malaria Prevention Cambodia

> **NCT01624337** · NA · TERMINATED · sponsor: **Armed Forces Research Institute of Medical Sciences, Thailand** · enrollment: 231 (estimated)

## Conditions studied

- Malaria

## Interventions

- **DRUG:** DHA-piperaquine
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01624337
- **Lead sponsor:** Armed Forces Research Institute of Medical Sciences, Thailand
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-05
- **Primary completion:** 2014-08
- **Final completion:** 2015-06
- **Target enrollment:** 231 (ESTIMATED)
- **Why stopped:** Medication safety concern
- **Last updated:** 2016-07-12

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01624337

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01624337, "Malaria Prevention Cambodia". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01624337. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*